Treatment Effect of Edaravone in Patients With Amyotrophic Lateral Sclerosis (ALS)

NCT03272802 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Neuromuscular Diseases

Interventions

DRUG: Edaravone
DRUG: Riluzole

Sponsor

Isfahan University of Medical Sciences